Published on
June 16, 2025
- 13:00 GMT
Atticus Pharma Completes Enrollment in the First Human Clinical Trial of ATC-002 for Androgenic Alopecia
ATC-002 is an Investigational Pharmaceutical Product Candidate for Androgenic Alopecia GREENVILLE, SC, UNITED STATES, June 16, 2025 /EINPresswire.com/ -- • ATC-002 is a twice-daily topical treatment designed to stimulate new hair growth in subjects …
Distribution channels:
Banking, Finance & Investment Industry, Beauty & Hair Care
...
